Viewing Study NCT03297502


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-01-07 @ 11:32 PM
Study NCT ID: NCT03297502
Status: COMPLETED
Last Update Posted: 2017-09-29
First Post: 2017-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
Sponsor: Par Pharmaceutical, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module